Table 1 Subject characteristics
| Sex | 5 F:13 M |
|---|---|
| Age: Mean (95% CI) | 65 (60–71) |
| FVC% predicted: Mean (95% CI) | 83.1 (74.1-92.1) |
| TLCO% predicted: Mean (95% CI) | 53.4 (44.8-62.1) |
| Proportion of subjects taking: | |
| Prednisolone | 5/18 |
| N-acetylcysteine | 6/18 |
| Azathioprine | 5/18 |
| Mycophenolate Mofetil | 1/18 |
